Association of Eumycetoma and Schistosomiasis

PLoS Neglected Tropical Diseases

Volumn 7, Issue 5, 2013, Pages

  van Hellemond, Jaap J ^a   Vonk, Alieke G ^a   de Vogel, Corné ^a   Koelewijn, Rob ^b   Vaessen, Norbert ^a   Fahal, Ahmed H ^c   van Belkum, Alex ^a,d   van de Sande, Wendy W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Harbour Hospital   (Netherlands)

^c UNIVERSITY OF KHARTOUM   (Sudan)

^d BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EUMYCETOMA; FEMALE; HEMAGGLUTINATION TEST; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TOXOPLASMA GONDII;

EID: 84878482960     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002241     Document Type: Article

References (33)

1. Ahmed A, van de Sande WWJ, Fahal A, Bakker-Woudenberg IA, Verbrugh H, et al. (2007) Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis 20: 146-151.
2. Abbott P, (1956) Mycetoma in the Sudan. Trans R Soc Trop Med Hyg 50: 11-24 discussion, 24-30.
3. Ahmed AO, van Leeuwen W, Fahal A, van de Sande WWJ, Verbrugh H, et al. (2004) Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 4: 566-574.
4. Gumaa SA, (1994) The Aetiology and Epidemiology of Mycetoma. Sudan Medical Journal 32: 14-22.
5. de Klerk N, de Vogel C, Fahal A, van Belkum A, van de Sande WW, (2012) Fructose-bisphosphate aldolase and pyruvate kinase, two novel immunogens in Madurella mycetomatis. Med Mycol 50: 143-151.
6. van de Sande WW, Janse DJ, Hira V, Goedhart H, van der Zee R, et al. (2006) Translationally controlled tumor protein from Madurella mycetomatis, a marker for tumorous mycetoma progression. J Immunol 177: 1997-2005.
7. Mhmoud N, Fahal A, Van de Sande WWJ, Polymorphisms of interleukin-10 and CCL5 genes in mycetoma. Med Mycol (submitted).
8. van de Sande WW, Fahal A, Tavakol M, van Belkum A, (2010) Polymorphisms in catechol-O-methyltransferase and cytochrome p450 subfamily 19 genes predispose towards Madurella mycetomatis-induced mycetoma susceptibility. Med Mycol 48: 959-968.
9. van de Sande WW, Fahal A, Verbrugh H, van Belkum A, (2007) Polymorphisms in genes involved in innate immunity predispose toward mycetoma susceptibility. J Immunol 179: 3065-3074.
10. Zhang L, Mia MY, Zheng CL, Hossain MA, Yamasaki F, et al. (1999) The preventive effects of incomplete Freund's adjuvant and other vehicles on the development of adjuvant-induced arthritis in Lewis rats. Immunology 98: 267-272.
11. Cavanagh LL, (1974) Attempts to induce mycetoma in monkeys and mice using Madurella mycetomi. Sabouraudia 12: 258-262.
12. Stills HF Jr, (2005) Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants. Ilar J 46: 280-293.
13. Ezenwa VO, Jolles AE, (2011) From host immunity to pathogen invasion: the effects of helminth coinfection on the dynamics of microparasites. Integr Comp Biol 51: 540-551.
14. Ahmed AO, Abugroun ES, (1998) Unexpected high prevalence of secondary bacterial infection in patients with mycetoma. J Clin Microbiol 36: 850-851.
15. Sacco R, Hagen M, Sandor M, Weinstock JV, Lynch RG, (2002) Established T(H1) granulomatous responses induced by active Mycobacterium avium infection switch to T(H2) following challenge with Schistosoma mansoni. Clin Immunol 104: 274-281.
16. Pearce EJ, MacDonald AS, (2002) The immunobiology of schistosomiasis. Nat Rev Immunol 2: 499-511.
17. Lang C, Gross U, Luder CG, (2007) Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol Res 100: 191-203.
18. van de Sande WW, Gorkink R, Simons G, Ott A, Ahmed AO, et al. (2005) Genotyping of Madurella mycetomatis by Selective Amplification of Restriction Fragments (Amplified Fragment Length Polymorphism) and Subtype Correlation with Geographical Origin and Lesion Size. J Clin Microbiol 43: 4349-4356.
19. Van Gool T, Vetter H, Vervoort T, Doenhoff MJ, Wetsteyn J, et al. (2002) Serodiagnosis of imported schistosomiasis by a combination of a commercial indirect hemagglutination test with Schistosoma mansoni adult worm antigens and an enzyme-linked immunosorbent assay with S. mansoni egg antigens. J Clin Microbiol 40: 3432-3437.
20. Harris JB, Podolsky MJ, Bhuiyan TR, Chowdhury F, Khan AI, et al. (2009) Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh. PLoS Negl Trop Dis 3: e403.
21. Du Y, Agnew A, Ye XP, Robinson PA, Forman D, et al. (2006) Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio. Microbes Infect 8: 52-60.
22. Gryseels B, Polman K, Clerinx J, Kestens L, (2006) Human schistosomiasis. Lancet 368: 1106-1118.
23. Abruzzi A, Fried B, (2011) Coinfection of Schistosoma (Trematoda) with bacteria, protozoa and helminths. Adv Parasitol 77: 1-85.
24. Actor JK, Shirai M, Kullberg MC, Buller RM, Sher A, et al. (1993) Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci U S A 90: 948-952.
25. Hassan MF, Zhang Y, Engwerda CR, Kaye PM, Sharp H, et al. (2006) The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani. Am J Pathol 169: 943-953.
26. Sangweme D, Shiff C, Kumar N, (2009) Plasmodium yoelii: adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model. Exp Parasitol 122: 254-259.
27. Mohamed AA, Mahgoub HM, Magzoub M, Gasim GI, Eldein WN, et al. (2009) Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan. Trans R Soc Trop Med Hyg 103: 1062-1064.
28. Mudawi HM, Smith HM, Rahoud SA, Fletcher IA, Babikir AM, et al. (2007) Epidemiology of HCV infection in Gezira state of central Sudan. J Med Virol 79: 383-385.
29. Mahgoub HM, Mohamed AA, Magzoub M, Gasim GI, Eldein WN, et al. (2010) Schistosoma mansoni infection as a predictor of severe anaemia in schoolchildren in eastern Sudan. J Helminthol 84: 132-135.
30. Abdel-Hameed AA, (1991) Sero-epidemiology of toxoplasmosis in Gezira, Sudan. J Trop Med Hyg 94: 329-332.
31. Schramm G, Haas H, (2010) Th2 immune response against Schistosoma mansoni infection. Microbes Infect 12: 881-888.
32. el Hassan AM, Fahal AH, Ahmed AO, Ismail A, Veress B, (2001) The immunopathology of actinomycetoma lesions caused by Streptomyces somaliensis. Trans R Soc Trop Med Hyg 95: 89-92.
33. Salinas-Carmona MC, Torres-Lopez E, Ramos AI, Licon-Trillo A, Gonzalez-Spencer D, (1999) Immune response to Nocardia brasiliensis antigens in an experimental model of actinomycetoma in BALB/c mice. Infect Immun 67: 2428-2432.